Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells

Infection and Immunity

Volumn 64, Issue 12, 1996, Pages 5295-5301

  Mahon, Bernard P ^a   Ryan, Mark S ^a   Griffin, Fiona ^a   Kingston, H ^a   Mills, G ^a  

^a ST PATRICK S COLLEGE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; GAMMA INTERFERON; HEMAGGLUTININ; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; RECOMBINANT INTERLEUKIN 12; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029834751     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.12.5295-5301.1996     Document Type: Article

References (44)

1. Ad Hoe Group for the Study of Pertussls Vaccine. 1988. Placebo-controlled trial of two accllular pertussis vaccines in Sweden - protective efficacy and adverse events. Lancet 1:955-960.
2. Afonso, L. C. C., T. M. Scharton, L. Q. Vlelra, M. Wyssocka, G. Trinchlerl, and P. Scott. 1994. The adjuvant effect of interlcukin-12 in a vaccine against Leishmania major. Science 263:235-237.
3. Bannatyne. R. M., and J. Jackowski. 1987, Protective efficacy of an endotoxin-depleted pertussis vaccine. Vaccine 5:268-269.
4. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and K. H. G. Mills. 1996. Thl/Th2 cell dichotomy in acquired immunity to Bunletella pertussis: varables in the in vivo priming and in vitru eytokine delecation techniques affect the classification of T cell subsets as Thl, Th2 or Th0. Immunology 87:372380.
5. Bliss, J., V. V, Cleave, K, Murray, A. Wiencis, M. Kelchum, K. Maylor. T. Halre, C. Resmini, A. K. Abbas, and S. K, Wolf. 1996. IL-12, as an adjuvant, promotes a T helper I cell, but does not suppress a T helper 2 cell recall response. J. Immunol. 156:887-894.
6. Cherry, J. D., P. A. Brunnell, G. S. Golden, and D. T. Karzon. 1988. Report of the task force on pertussis und pertussis immunization-1988. Pediatrics 81(Suppl.):939-984.
7. Ewanowich, C. A., A. R. Melton, A. A. Weiss, K. K. Sherburne, and M. S. Peppier. 1989, Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect. Immun. 57:2698-2704.
8. Flynn, J. L., M. M. Goldstein, K. J, Triebold, J. Sypek. S. F. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycabacterium tuberculosis infection. J. Immunol. 155:2515-2524.
9. Friedman, R. L., K. Nordensson, L. Wilson, E. T. Akporiaye, and D. E. Yocum. 1992. Uptake and intraccllular survival of Bordetella pertussis in human macrophages. Infect. Immun. 60:4578-4585.
10. Gajewski, T. K., M. Pinnas, T, Wong, and F. W. Fitch, 1991. Murine Th 1 and Th2 clones prolifcrate optimally in response to distinct antigen presenting cell populations. J. Immunol. 146:1750-1758.
11. Gazzinelll, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher, 1993. Interleukin 12 is required for T-lymphocyte-independent induction of interferon-γ by an intrucellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115-6119.
12. Greco, D., S. Salmaso, P. Mastrantonlo. M. Guiliano, A. G. Tozzi, A. Anemona, M. L. Glori Delgi Atti, A. Glammanco, P. Panel, W. C. Blackwelder, D. L. Klein, S. G. F. Wassilak, and the Progetto Pertosase Working Group. 1996. A controlled trial of two accllulur vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
13. Gustafsson. L., H. O. Hallander, P. Olin, E. Reizensteln, and J. Storsaeter. 1996. A controlled trial of a two-component accllular, a five component acellular, and a whole cell pertussis vaccine. N. Engl. J. Med. 334:349-355.
14. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505-1509.
15. Hsieh, C.-S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of Th 1 CD4' T cells through IL-12 produced by Listeria-induced microphages. Science 260:547-549.
16. Hunter, C. A., C. S. Subauste, V. H. van Cleave, and J, S. Remington. 1994. Production of gamma interferon hy natural killer cells from Toxoplaama gondii-infectcd SC1D mice: regulation by inlerleukin-10, interleukin-12, and tumor neerosis factor alpha, Infect. Immun. 62:2818-2824.
17. Mahon, B. P., K. Katruk, A. Nomoto, A. J. Macadam, P. D. Minor, and K. H. G. Mills. 1995. Poliovirus-specilic CD4' Thl clones with both cytoloxic and helper activity mediate protective humoral immunity against a lethal poliovirus infuction in transgenic mice expressing the human poliovirus raceptor. J. Exp. Med, 181:1285-1292.
18. McKnight, A. J.,G. J. Zimmer, I. Fogelman. S. F. Wolf, and A. A. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172-2179.
19. Miller, M. A., M. J. Skeen, and H. K. Ziegler. 1995. Nonviahle bacterial antigens administered with IL.-12 generate protective immunity against Listeria monocytogenes. J. Immunol. 155:4817-4828.
20. Mills, K, H. G., A, Barnard, J. Watkins, and K. Redhead. 1993. Cellmediated immunity to Bordetella pertussis role of T'hl cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
21. Mills, K. H. G., and K. Redhead, Cellular immunity in pertussis. 1993. J. Med. Microbiol.39:163-164.
22. Moore, A., P. McGulrk, S. Adams. W. C. Jones, J. P. MeGee, D. T. O'Hagun. and K. H. G. Mills. 1995. Induction of HIV-specific CD8' cytotoxic T lymphocytes and CD4' Thl cells hy immunisation with recombinant gp l20 entrapped in biodegradable microparticles. Vaccine 13:1741-1744.
23. Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause. B. R, Hubbard, M. C. Gately, and F. D. Finkleman. 1994, Effects of 11-12 on in vivo cytokine gene expression and Ig isotype selection, J. Immunol 152:1047-1056.
24. Mosmann, T. R., and R. L. Coffman. 1989. Heterogencity of cylokine secretion patterns and functions of helper T cells. Adv. Immunol 46:111-147.
25. 2?. O'Gara, A., and K. Murphy. 1994. Role of cytokines in determining Tlymphocyte function. Curr. Opin. Immunol. 6:458-466.
26. 2o, Orange, J. S., and C. A. Blron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1138-1142.
27. Peppoloni, S., L, Nencioni, A. Tommaso, A, Tagllabue, P. Parronchi, S, Romagnanl, R. Rappuoll, and M. T. De Magistris, 1991. Lymphokine secretion and cytotoxic activity of human CD4 T-cell clones agninst Bordetella pertussis. Infect. Immun. 59:3768-3773.
28. Peterson, J. P., P. H. Ibsen, K. Haslav. and I. Heron, 1992. Proliferative responses and gamma Interferon and lumor necrosis factor production by lymphocytes isolated from trachcobroncheal lymph nodes and spleens of mice aerosol infected with Bordetella pertussis. Infect. Immun. 60:4563-4570.
29. Redhead, K., A. Barnard, J. Walkins. and K. H. G. Mills. 1993. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on the induction of cell-mediated immunity. Infect. Immun. 61: 3190-3198.
30. Robinson, A., L. I. Irons, and L. A. E, Ashworth. 1985. Pertussis vaccine: present status and future prospects. Vaccine 3:11-22.
31. Ryan, M., L Gothefors, J. Storsaeter, and K. H. G. Mills, B. pertussis-specfic Thl/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cylokine profiles in infants and mice. Dev. Biol. Stand., in press.
32. 31a.Ryan, M. S., and K. H.G. Mills, Unpublished observations.
33. Salo, Y., K. Izumlya, H, Sato, J, L,. Cowell, and C. R. Manclark. 1980. Aerosol infection of mice with Bordetella pertussis Infect. Immun. 29:261-266.
34. Saukkonen, K., C. Cabellos, M. Burroughs, S, Prasad, and E, Tunmanen. 1941. The role of the interaction between Bordetella pertussis and macrophages in pulmonary colonization. J. Exp. Med. 173:1143-1149.
35. Schijns, V. E. C. J., B. L., Haagmans, and M. C., Horazlnek. 1995. IL-12 stimulates an antiviral type 1 cytokine response but lucks adjuvant activity in IFN-TM-cccplor deficient mice. J. Immunol, 155:2525-2532.
36. Seder, R. A., R. Gazzinelli, A. Sher, and W, E. Paul, 1993. Inlerleukin 12 acts directly on CD4 ' T cells to enhance priming for interferon-γ production and diminishes interlcukin 4 inhibition of such priming. Proc. Null. Acad. Sci. USA 90:101188-10142.
37. Sidley, F. M., B, L. Furman, and A. C. Wardlaw. 1989. Effect of hyperreactivity to endotoxin on the toxicily of pertussis vaccine and pertussis toxin in mice. Vaccine 7:237-241,
38. Skeen, M. J., M. A. Miller, T. M. Shinnick. and H. K. Ziegler, 1996. Regulation of murine macrophage II.-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other eylokines, J. Immunol. 156:1196-1206.
39. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M, Subrumanjam. S. J. Goldman, D, S. Sieburth, S. F. Wolf, and R. G. Schauh, 1993. Resolution of cutaneous leishmaniasis: inlerleukin 12 initiates a protective T helper type I immune response. J. Exp. Med. 177:1797-1802.
40. Trinchierl, G. 1995 lnlerlcukin-12: a proinllammatory cytokine with immu- noregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:25l-276.
41. Tripp, C, S., M. K. Gately. J. Hakiml, P. Ling, and E, R. Unanue, 1994. Neutralization of IL.-12 decreases resistance to Listeria in SCID and CBI7 mice: reversal by 1FN-γ. J. Immunol. 152:1883-1887.
42. Urban, J. F., R, Fayer, S.-J. Chen, W. C, Gause, M, K. Gately. and F. D. Finkelman. 1996. IL-12 protects immuncompetent and immunodeficient neonatal mice against infection with cryptosporidium parnum J. Immunol. 156:263-268.
43. Wynn, T. A., I. Eltoum, I. P. Oswald, A. W. Cheever, and A. Sher. 1994. Endogenous interleukin-12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1551-1561.
44. Zhan, V., and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance Brucella abortus infection. Infect. Immun. 63:1387-1340.